Image source: Novocure.What: Investors in Novocure (NASDAQ: NVCR), a commercial-stage medical-device company focused on oncology, are having a rough day. The company's stock is crashing, down more than 29% as of 4:00 p.m. EDT on heavy volume after it reported disappointing second-quarter results.Continue reading